Arrowhead Pharmaceuticals

arrow bullseye target on target
Pharma

Arrowhead strikes true with first FDA approval

Complicating things is the fact that Arrowhead’s first marketed product will now compete directly with the inaugural launch from its legal foe, Ionis.
Fraiser Kansteiner Nov 18, 2025 3:44pm
Three blocks displaying from left to right a person a handshake and another person

Ionis, Arrowhead sponsor new triglyceride education group

Mar 28, 2025 10:10am
rare diseases

Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025

Feb 28, 2025 10:18am
Arrowheads Well Get There Soon campaign

Arrowhead targets rare disease patients with awareness campaign

Nov 5, 2024 11:58am
money arrow target

Arrowhead's plozasiran could reach $700M-plus in sales: report

Apr 16, 2024 3:05pm
Illustration connected puzzle pieces with the acronym MA

Alnylam, Intra-Cellular among RBC's top picks for M&A

Apr 19, 2023 3:20pm